Sign in →

Test ID RZIKU Zika Virus, PCR, Molecular Detection, Random, Urine

Useful For

Qualitative detection of Zika virus RNA in serum and urine from individuals meeting CDC Zika virus clinical or epidemiologic criteria

Highlights

Provides qualitative detection of Zika virus RNA from urine collected during the acute phase of infection.

            

This test is intended for the evaluation of pregnant women and symptomatic nonpregnant individuals with potential exposure to Zika virus.

 

Due to similar clinical presentations, testing for RNA or IgM-class antibodies to dengue and chikungunya viruses, concurrently with Zika virus testing, is strongly recommended.

 

For the most up-to-date Zika epidemiology and testing recommendations, visit www.cdc.gov/zika/

Testing Algorithm

The FDA requires that urine specimens be tested in conjunction with a paired serum specimen; order RZIKS / Zika Virus, PCR, Molecular Detection, Serum for the paired serum specimen.

 

The following algorithms are available in Special Instructions:

-Assessment for Zika Virus Infection in Nonpregnant Individuals

-Assessment for Zika Virus Infection in Pregnant Individuals

Method Name

Real-Time Reverse Transcription Polymerase Chain Reaction (PCR)/DNA Probe Hybridization

Reporting Name

Zika Virus, PCR, Urine

Specimen Type

Urine

Specimen Required

Container/Tube: Sterile container

Specimen Volume: 1 mL

Collection Instructions:

1. Collect random urine in a sterile container.

2. Label specimen as urine.

Specimen Minimum Volume

0.3 mL

Specimen Stability Information

Specimen Type Temperature Time
Urine Refrigerated (preferred) 7 days
  Frozen  7 days

Reference Values

Negative

Day(s) and Time(s) Performed

Tuesday, Thursday; 7 a.m.

Performing Laboratory

Mayo Medical Laboratories in Rochester

Test Classification

This test has been cleared or approved by the U.S. Food and Drug Administration and is used per manufacturer's instructions. Performance characteristics were verified by Mayo Clinic in a manner consistent with CLIA requirements.

CPT Code Information

87798

LOINC Code Information

Test ID Test Order Name Order LOINC Value
RZIKU Zika Virus, PCR, Urine 79190-5

 

Result ID Test Result Name Result LOINC Value
47916 Zika Urine PCR Result 79190-5
PREG1 Is patient pregnant? 11449-6
EXPO1 Has patient had Zika exposure? In Process
SYMP1 Has patient been symptomatic? In Process
48058 Zika Urine Interpretation 69048-7

Necessary Information

Order questions and answers concerning pregnancy, exposure, and display of symptoms are required.

Additional Testing Requirements

The FDA requires that urine specimens be tested in conjunction with a paired serum specimen; order RZIKS / Zika Virus, PCR, Molecular Detection, Serum for the paired serum specimen.